B6J;B6NTac-Gfm1em1Rmrt/Gfm1em2Rmrt/Cnbc

Status

Available to order

EMMA IDEM:14606
Citation informationRRID:IMSR_EM:14606 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6J;B6NTac-Gfm1em1Rmrt/Gfm1em2Rmrt/Cnbc
Alternative nameGfm1R671C/-
Strain typeEndonuclease-mediated
Allele/Transgene symbolGfm1em2Rmrt, Gfm1em1Rmrt
Gene/Transgene symbolGfm1, Gfm1

Information from provider

ProviderRamón Martí
Provider affiliationVall d’Hebron Research Institute (VHIR)
Additional ownerConsorcio Centro de Investigación Biomédica en Red M.P. (CIBER)
Genetic informationGfm1 encodes the mitochondrial elongation factor G1. We have generated a compound heterozygous mutant mouse model that harbours a knock-out (KO) mutation in one allele and a knock-in (KI) mutation in the other allele. The KO allele consists in the deletion of exons 2 and 3 causing a frameshift that results in a premature stop codon in exon 4. The KI mutation is a two-base pairs insertion/deletion in exon 16, causing a missense mutation that induces the replacement of arginine by cysteine at position 671 of the protein sequence. CRISPR technology details: CRISPR mutagenesis done by Taconic, Cas9 has not been integrated in the mouse genome.
Phenotypic informationHomozygous:
Homozygous KO mutation is embryonic lethal (before 10.5 dpc). Homozygous KI mutation causes a reduction of the mitochondrial translation rate and mitochondrial oxidative phosphorylation deficiency in the liver (complex IV deficiency).

Heterozygous:
KI/KO compound heterozygous mice show reduced mitochondrial translation rate in liver and brain, combined oxidative phosphorylation deficiency in liver and brain (complex I and complex IV), decrease of body weight in pre-weaning female mice and reduced levels of triacylglycerides in adult mice. There are also signs of hepatic microsteatosis in young and adult mice.
Breeding historyThe KI allele was generated in the C57BL/6NTac inbred strain, and Gfm1R671C/+ mice were crossed with wild-type C57BL/6NTac mice for one generation. Heterozygous (Gfm1R671C/+) G1 mice were bred for an additional generation. Then, inbred G2 mice stopped to be reproductive and we bred heterozygous (Gfm1R671C/+) C57BL/6NTac G2 male mice with wild-type homozygous C57BL/6J mice, resulting in heterozygous (Gfm1R671C/+) mice in a C57BL/6 mixed background. The KO allele was generated in the C57BL/6NTac inbred strain, and heterozygous (Gfm1-/+) mice were bred for one generation. G1 heterozygous (Gfm1-/+) mice were bred with C57BL/6 heterozygous (Gfm1R671C/+) mice to obtain the compound heterozygous mouse model (Gfm1R671C/-). The colony was maintained by breeding Gfm1-/+ with Gfm1R671C/+ for two additional generations.
References
  • Dysfunctional mitochondrial translation and combined oxidative phosphorylation deficiency in a mouse model of hepatoencephalopathy due to Gfm1 mutations.;Molina-Berenguer Miguel, Vila-Julià Ferran, Pérez-Ramos Sandra, Salcedo-Allende Maria Teresa, Cámara Yolanda, Torres-Torronteras Javier, Martí Ramon, ;2022;FASEB journal : official publication of the Federation of American Societies for Experimental Biology;36;e22091; 34919756
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivinghomozygous (EM:14606 backg., mixed C57BL/6) males, homozygous (EM:14606 backg., mixed C57BL/6) females
Stage of embryos2-cell

Disease and phenotype information

IMPC phenotypes (gene matching)
  • increased circulating triglyceride level / IMPC
  • hyperplasia / IMPC
  • extramedullary hemopoiesis / IMPC

Literature references

  • Dysfunctional mitochondrial translation and combined oxidative phosphorylation deficiency in a mouse model of hepatoencephalopathy due to Gfm1 mutations.;Molina-Berenguer Miguel, Vila-Julià Ferran, Pérez-Ramos Sandra, Salcedo-Allende Maria Teresa, Cámara Yolanda, Torres-Torronteras Javier, Martí Ramon, ;2022;FASEB journal : official publication of the Federation of American Societies for Experimental Biology;36;e22091; 34919756

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).